Semaglutide vs Tirzepatide (Ozempic vs Zepbound): A Physician's Comparison

By Dr. Sabeen Munib, MD, Physician at The Pur Health, Irvine & Orange County

Semaglutide and tirzepatide are the two medications behind almost every weight loss conversation right now, and the brand names add to the confusion. Here is the honest comparison I give patients in my Irvine office, including what the trials actually show and how I decide between them.

The Short Version

Semaglutide is the active ingredient in Ozempic and Wegovy. Tirzepatide is the active ingredient in Mounjaro and Zepbound. The key mechanical difference is that semaglutide acts on one gut hormone pathway (GLP-1), while tirzepatide acts on two (GLP-1 and GIP). That dual action is why tirzepatide tends to produce more weight loss for many patients, though it is not automatically the right choice for everyone.

Weight Loss: What the Trials Show

In the major trials, tirzepatide produced greater average weight loss than semaglutide. At the highest doses, tirzepatide studies reported average reductions in the range of 20 percent of body weight, while semaglutide studies landed closer to 15 percent. Real-world results vary widely and depend on dose, consistency, and everything around the medication. Averages are not promises.

Side Effects

The side effect profiles are similar. Both are GLP-1 based and most commonly cause nausea, constipation, or diarrhea, usually early and usually manageable with slow titration. The single biggest factor in tolerability is how carefully the dose is increased, which is exactly why physician supervision matters more than which brand you start on.

Cost

Both are expensive at retail without insurance, often around 1,000 dollars or more per month for the brand versions. What you actually pay depends on coverage, savings programs, and whether a compounded option is appropriate. We break the numbers down in our guide to what these medications cost without insurance.

Which Is Right for You?

For many eligible patients we now lean toward tirzepatide because of the stronger average results, but semaglutide remains a good fit in plenty of cases, including patients who tolerate it well or have cost or supply reasons to prefer it. The decision comes down to your labs, your history, your tolerance, and your goals. We go deeper on this in our semaglutide guide.

Frequently Asked Questions

Is tirzepatide better than semaglutide?

On average, tirzepatide produced more weight loss in trials. Better for you specifically depends on how you tolerate it, your cost and coverage, and your medical history. More weight loss on paper does not always mean the right choice for a given patient.

Is Zepbound the same as Mounjaro?

They are the same medication, tirzepatide, from the same manufacturer. Zepbound is branded for weight management and Mounjaro for type 2 diabetes. Ozempic and Wegovy have the same relationship for semaglutide.

Can you switch from semaglutide to tirzepatide?

Yes, and many patients do. The switch should be done with physician guidance so the starting dose and titration are set correctly, since the two are not dosed the same way.

If you are trying to decide between them, book a consultation and we will match the medication to your labs and history rather than to the hype.

Sabeen Munib, MD

Physician, The Pur Health, Irvine & Orange County